We next quantified the levels of circulating cell-free DNA (cfDNA) and NETs (myeloperoxidase-DNA [MPO-DNA] complexes) in patient plasma and again observed significantly elevated NETs and cfDNA in the plasma of patients with COVID-19 (Figure 3, C and D), as previously reported (16, 17). The gene discussed is MPO; the disease is COVID-19.